Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does NANDROLONE DECANOATE Cause Ventricular hypertrophy? 6 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Ventricular hypertrophy have been filed in association with NANDROLONE DECANOATE. This represents 6.1% of all adverse event reports for NANDROLONE DECANOATE.

6
Reports of Ventricular hypertrophy with NANDROLONE DECANOATE
6.1%
of all NANDROLONE DECANOATE reports
1
Deaths
6
Hospitalizations

How Dangerous Is Ventricular hypertrophy From NANDROLONE DECANOATE?

Of the 6 reports, 1 (16.7%) resulted in death, 6 (100.0%) required hospitalization.

Is Ventricular hypertrophy Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for NANDROLONE DECANOATE. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does NANDROLONE DECANOATE Cause?

Drug abuse (45) Off label use (13) Hypertension (9) Intentional product misuse (9) Polycythaemia (8) Acne (7) Testicular atrophy (6) Toxic cardiomyopathy (6) Acne fulminans (5) Acute kidney injury (5)

What Other Drugs Cause Ventricular hypertrophy?

AMLODIPINE (46) PREDNISONE (37) PANTOPRAZOLE (36) ASPIRIN (32) VALSARTAN (29) CLOZAPINE (28) ACETAMINOPHEN (27) TIOTROPIUM (24) ALBUTEROL (21) ONDANSETRON (21)

Related Pages

NANDROLONE DECANOATE Full Profile All Ventricular hypertrophy Reports All Drugs Causing Ventricular hypertrophy NANDROLONE DECANOATE Demographics